Freight News, Logistics, Forwarding

Geodis gains GDP in China

[ March 16, 2022   //   ]

Geodis has obtained Good Distribution Practice (GDP) Accreditation in China to meet the demands of the growing healthcare market.

The forwarder said that with Covid-19 exposing the emerging risks and weaknesses of the pharmaceutical industry’s supply chain, this accreditation underscored its commitment to ensuring the quality and integrity of pharmaceutical products for its customers across the logistics ecosystem.

Following the stringent requirements published by the Chinese Ministry of Health (MOH) in 2013, GDP certification requires comprehensive audits of operational procedures in warehouses, ensuring that they are compliant with the highest industry standards to handle pharmaceutical products. 

President and chief executive, Asia Pacific, Onno Boots, said: “Geodis is fully committed to ensuring our pharmaceutical and healthcare customers’ success in maintaining their delivery standards and reputation for high-quality products. This GDP accreditation demonstrates our continued dedication to providing industry-leading solutions and services in every aspect to meet the high standards set by China’s Ministry of Health.”

Geodis’ operations in India, Korea, Thailand and Singapore are also in the process of receiving certification from the IATA Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma), which ensures international and national compliance to safeguard product integrity, whilst specifically addressing the requirements for air cargo handling and transport.